Huntington's disease (HD) is an incurable neurological disorder caused by an abnormal glutamine repeat expansion in the huntingtin (Htt) protein. In the present studies we investigated the role of Transducers of Regulated cAMP response element binding protein (CREB) activity (TORCs) in HD, since TORCs play an important role in expression of the transcriptional co-regulator PGC-1α, whose expression is impaired in HD. We found significantly decreased TORC1 expression levels in STHdhQ111 cells expressing mutant Htt, in the striatum of NLS-N171-82Q, R6/2 and HdhQ111 HD transgenic mice, and in postmortem striatal tissue from HD patients. TORC1 over expression in wild type and Htt striatal cells increased CREB mRNA and protein levels, PGC-1α promoter activity, mRNA expression of the PGC-1α, NRF-1, Tfam and CytC genes, mitochondrial DNA content, mitochondrial activity and mitochondrial membrane potential (MMP). TORC1 over expression also increased the resistance of striatal cells to 3-nitropropionic acid (3-NP) mediated toxicity. In cultured wild-type-and mutant Htt striatal cells, shRNA mediated TORC1 knock down resulted in decreased PGC-1α expression, and increased susceptibility to 3-NP induced toxicity. Over expression of PGC-1α partially prevented TORC-1 knock down mediated increased susceptibility of huntingtin striatal cells to 3-NP. Specific knock down of TORC1 in the striatum of NLS-N171-82Q HD transgenic mice induced neurodegeneration. Lastly, knock down of Htt prevents transcriptional repression of TORC-1 and CREB in Htt striatal cells. These findings show that impaired expression and function of TORC1, which results in reduction of PGC-1α, plays an important role in mitochondrial dysfunction in HD. by guest on November 8, 2016 http://hmg.oxfordjournals.org/ Downloaded from Introduction Huntington's disease (HD) is an incurable and fatal autosomal-dominant neurodegenerative disease, characterized by neuronal degeneration in the striatum, and other regions of the brain, with progressive behavioral and cognitive deficits and involuntary choreiform movements. HD is caused by an abnormal CAG repeat expansion in exon 1 of the HD gene, resulting in formation of an increased polyglutamine region in the mutant huntingtin (Htt) protein. How the mutant Htt protein elicits its toxic effects remains elusive, but several mechanisms have been postulated including transcriptional dysregulation, abnormalities in mitochondrial energy metabolism, protein aggregation, protein disposal, and oxidative damage (1). Mitochondrial dysfunction and bioenergetic defects in HD occur by several different mechanisms (1-5). First, mutant Htt may interact directly with mitochondria. Studies in an HD mouse model and cultured HD striatal cells (STHdhQ111), show that mutant Htt associates directly with the outer mitochondrial membrane (6). Electron microscopic studies in neurons show localization of N-terminal mutant Htt on mitochondria (7). Second, mutant Htt impairs in vitro and in vivo trafficking of mitochondria in neurons, leading to loss of mitochondrial motility and eventually to mitochondrial dysfunction (8-10). Third, mutant Htt impairs mitochondrial function by altering gene transcription (11, 12) . Mutant Htt directly interacts with, and down regulates the activity of several transcription factors including p53, cAMP response element binding protein (CREB), TAFII130 and SP1 (13-16). CREB is reduced in HD and mutant Htt represses the expression of CREB by a direct interaction with the CREB binding protein (CBP) (13, 14, (17) (18) (19) (20) . Overexpression of CBP rescues polyglutamine induced neuronal toxicity (14).
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critical role in dendritic growth of developing cortical neurons, through positive regulation of activity-dependent CREB-target gene transcription (29). In Drosophila, TORC promotes stress resistance, and maintains energy balance under starvation conditions, by induction of CREB target genes in the brain (30, 31) . TORCs also enhance neuronal survival after ischemia by activation of CREB target genes (32) .
TORCs are known to be critical regulators of both CREB and PGC-1α expression, whose transcription and activity are decreased in HD. Furthermore, both CREB and PGC-1α knockout mice exhibit specific degeneration of hippocampal and striatal neurons, and phenotypes reminiscent of HD (33) (34) (35) . We therefore, investigated TORC activity and function in HD striatal cells, HD transgenic mice, and postmortem brain tissue from HD patients.
Results:

Impaired TORC1 mRNA transcription and protein levels in the striatum of HD transgenic mice lines and huntingtin striatal cells
Decreased PGC-1α and CREB transcription appear to play an important role in HD pathogenesis. TORC1 is a strong inducer of CREB transcription, which increases PGC-1α promoter activity, transcription and mitochondrial biogenesis (28) . We therefore investigated whether TORC dysfunction contributes to impairment of PGC-1α and CREB expression in HD. We analyzed TORC1, TORC2 and TORC3 mRNA expression, and protein levels, in HD striatal cell lines, in the striatum and cerebral cortex of three different HD transgenic mouse models, and in HD postmortem brain tissue. We utilized NLS-N171-82Q, R6/2 and Hdh-Q111 knockin HD transgenic mice and striatal STHdhQ111 cells, an immortalized cell line made from the Hdh-Q111 mice (36) (37) (38) (39) .
by guest on November 8, 2016 http://hmg.oxfordjournals.org/ Downloaded from 6 We found significantly decreased TORC1 and TORC2 mRNA expression in the striatum of NLS-N171-82Q HD mice as compared to WT mice ( Fig 1A) . TORC3 mRNA expression was not significantly altered in these mice. In the striatum of the R6/2 and Hdh-Q111 HD mice, TORC1 mRNA expression was significantly reduced by 30% and 52% respectively as compared to WT, however, there were no significant alterations in TORC2 and TORC3 mRNA expression ( Fig 1B and 1C) . The TORC1 mRNA expression was significantly decreased in STHdhQ111/Q111 striatal cells (expressing endogenous mutant Htt with 111CAG repeats) as compared to wild type STHdhQ7/Q7 (expressing endogenous normal huntingtin) ( Fig 1D) , but there were no significant changes in TORC2 and TORC3 mRNA expression ( Fig 1D) . We observed a significant decrease in TORC1 protein levels in the NLS-N171-82Q, R6/2 and Hdh-Q111 HD transgenic mice, as compared to their respective wild type mice ( Fig 1E and 1F) . These results show that there are both decreased TORC1 mRNA expression and protein levels in the HD transgenic mice, and immortalized striatal cells expressing mutant huntingtin.
Decreased TORC1 transcription and protein levels in the striatum of HD patients
We examined whether decreased transcriptional expression of TORC1 observed in the HD transgenic mice and huntingtin striatal cells also occurs in HD patients. We carried out qRT-PCR analysis of mRNA expression of the TORC isoforms in striatal brain tissue from age-matched control subjects, and symptomatic HD patients. We found a significant decrease (52%) of TORC1 mRNA expression in the striatum of HD patients as compared to control subjects ( Fig. 2A ). We also analyzed mRNA expression of TORC2 and TORC3. TORC2 mRNA expression was unchanged in the HD patients (Fig 2A) but TORC3 mRNA was significantly increased in the HD patients as compared to normal controls (Fig 2A) . We examined TORC1 protein levels in the striatum of HD patients and control subjects using western blots. There were significantly by guest on November 8, 2016 http://hmg.oxfordjournals.org/ Downloaded from decreased TORC1 protein levels in the striatum of HD patients ( Fig 2B&C) . These results show that both TORC1 transcription and protein levels are reduced in the striatum of HD patients.
TORC1 over expression induces TORC1, CREB, and PGC-1 transcription and PGC-1
promoter activity in the huntingtin striatal cells:
In order to assess, whether TORC1 over expression can induce CREB and PGC-1 transcription and activity, we over expressed TORC1 in wild type STHdhQ7 (Q7/7) and HD STHdhQ111 (Q111/111) striatal cells using a TORC1 plasmid. We found significantly decreased TORC1 mRNA expression in the STHdhQ111 cells, as compared to STHdhQ7 cells, ( Fig 3A) . TORC1 over expression resulted in a significant up regulation of TORC1 mRNA expression in the STHdhQ111 and STHdhQ7 cells ( Fig 3A) . TORC1 over expression also caused a significant increase in TORC1 protein levels in both cell types ( Fig 3B) . TORC1 is a nuclear protein that functions as a transcriptional coactivator, and activates CREB transcription through cAMP response element (CRE) sites (27) . TORC1 also regulates activity-dependent CREB target gene expression, and maintains dendrite growth of cortical neurons, and long-term potentiation in the hippocampus (29, 40).
We next investigated whether TORC1 over expression could affect CREB mRNA expression and protein levels. As shown in Fig 3C, basal CREB mRNA expression was significantly decreased in the STHdhQ111 cells as compared to STHdhQ7 cells, transfected with vector only. TORC1 over-expression caused significantly increased CREB mRNA expression in STHdhQ111 and STHdhQ7 cells ( Fig 3C) . Phosphorylation of CREB leads to activation of CREB-mediated gene transcription (41) , therefore, we assessed the effects of TORC1 over expression on CREB phosphorylation in HD striatal cells. We observed significantly decreased basal and phosphorylated CREB protein levels in empty vector transfected STHdhQ111 cells as by guest on November 8, 2016 http://hmg.oxfordjournals.org/ Downloaded from compared to STHdhQ7 cells ( Fig 3D) . The levels of both, basal and phosphorylated CREB proteins were markedly up regulated by TORC1 over expression in both STHdhQ111 and STHdhQ7 cells ( Fig 3D) . Furthermore, we examined the effects of TORC1 over expression on PGC-1 transcription. PGC-1 transcript expression was significantly increased in the STHdhQ111 and STHdhQ7 cells transfected with a TORC1 plasmid as compared with the empty vector control ( Fig 3E) . We next investigated whether TORC1 over expression affects PGC-1 promoter activity. We transiently transfected the STHdhQ111 and STHdhQ7 striatal cells with a pGL3-PGC-1 promoter-reporter construct containing the PGC-1 promoter encompassing -2533 to +78 of the mouse PGC-1 gene, fused to luciferase termed pGL3-PGC-1-Luc. We observed a significant inhibition of the luciferase reporter activity in the mutant STHdhQ111 compared to the wild-type STHdhQ7 cells, showing decreased PGC-1 promoter activity as a consequence of mutant Htt ( Fig 3F) . We next did transient co-transfection of pGL3-PGC-1-Luc with TORC1 plasmids. Over expression of TORC1 resulted in significantly increased PGC-1 promoter activity in both cell types ( Fig 3F) . These results show that TORC1 significantly increases CREB and PGC-1 expression and activity in wild type and mutant Htt striatal cells.
Over expression of TORC1 increases the expression of mitochondrial biogenesis genes and mitochondrial DNA content
Increased PGC-1 promoter activity observed following TORC1 over expression prompted us to ask, whether TORC1 also affects PGC-1 downstream transcription targets including the mitochondrial biogenesis genes, and mitochondrial DNA content in the STHdhQ111 and STHdhQ7 cells. PGC-1 plays a prominent role in regulating mitochondrial biogenesis and by guest on November 8, 2016 http://hmg.oxfordjournals.org/ Downloaded from cellular respiration by modulating the expression of transcription factors such as the mitochondrial transcription factor Tfam, a nuclear encoded mitochondrial transcription factor, and a target of NRF-1, which after translocation to mitochondria increases the transcription and replication of the mitochondrial genome which leads to mitochondrial biogenesis (42) (43) (44) . PGC-1, which is a transcriptional co-activator, acts in concert with CREB, and NRF-1 to enhance CytC expression.
We, therefore, assessed the effects of TORC1 over expression on the expression of the PGC-1 downstream target genes, NRF-1, Tfam and CytC in the STHdhQ111 and STHdhQ7 striatal cells ( Fig 4A) . As shown in Fig Fig 4A) .
We next examined the effects of TORC1 expression on numbers of mitochondria, and mitochondrial DNA content, in the STHdhQ7 and STHdhQ111 striatal cells. We examined the ratio of mRNA for COX-II, a mitochondrial DNA encoded gene, to the mRNA for 18s rRNA, a nuclear encoded transcript, which is a reliable indice of mitochondrial DNA content (45) . There was a significant reduction in the COX II/18s rRNA ratio in the STHdhQ111 cells at baseline, as compared to STHdhQ7 cells ( Fig 4B) . Following TORC1 over expression, there was a significant increase in COXII/18s rRNA ratio in both types of cells, consistent with increased mitochondrial DNA content ( Fig 4B) . These results show that TORC1 over expression significantly increases expression of PGC-1 downstream target genes and mitochondrial DNA content. 
TORC1 expression protects against mitochondrial dysfunction and toxicity induced by the mitochondrial toxin 3-NP in both wild type and mutant Htt striatal cells
In order to assess the effects of TORC1 expression on mitochondrial dysfunction and mitochondrial energy metabolism in HD, we transiently transfected mutant Htt striatal cells with TORC1 plasmids, followed by treatment with the mitochondrial toxin 3-NP, which inhibits complex II of the respiratory chain. STHdhQ111 striatal cells display low mitochondrial ATP production, and show increased vulnerability to 3-NP (46) . We studied the effects of TORC1 on in striatal cells after TORC1 and 3-NP treatment. We next studied mitochondrial activity and cell viability using the MTT assay in the STHdhQ111 striatal cells following TORC1 over expression and 3-NP treatment. The MTT assay relies on the reduction of yellow soluble tetrazolium salt to insoluble purple formazan by the mitochondrial succinate dehydrogenase enzyme, which is an index of mitochondrial activity. Treatment with 3-NP significantly decreased the MTT activity in the STHdhQ111 striatal cells, as compared to untreated cells ( Fig 5C) . Transient transfection of cells from the 3-NP mediated decreases in MTT ( Fig 5C) . These results therefore show that TORC1 over-expression increases mitochondrial activity and protects STHdhQ111 cells against 3-NP induced toxicity.
TORC1 knock down reduces PGC-1 mRNA expression and enhances mitochondrial dysfunction and susceptibility of huntingtin striatal cells to 3-NP
The neuroprotection provided by TORC1 to the huntingtin striatal cells against 3-NP induced toxicity, prompted us to analyze whether knockdown of TORC would make striatal cells more susceptible to mitochondrial dysfunction. We examined the effects of transient knockdown of TORC1 in STHdhQ111 striatal cells using two TORC1 shRNA sequences. We observed significantly decreased TORC1 mRNA expression following TORC1 shRNA transfection in striatal cells ( Fig 6A) , and both the TORC1 shRNAs had almost equal knock down efficiency, 6D&E). These observations show that TORC1 knockdown in the STHdhQ111 striatal cells significantly worsened 3-NP mediated reductions in MMP and mitochondrial activity.
Over expression of PGC-1α partially prevents TORC-1 knock down mediated susceptibility of huntingtin striatal cells to 3-NP
We next examined whether over expression of PGC-1α prevents deleterious effects of TORC1 down-regulation in huntingtin striatal cells. We transiently co-transfected STHdhQ111 and STHdhQ7 cells with PGC-1α over expressing plasmids and TORC-1 shRNA. TORC1 knock down significantly decreased the Mitotracker red fluorescence and mitochondrial activity, which was partially but not significantly prevented by PGC-1α over expression ( Fig 6D&E) . TORC1 knock down in combination with 3-NP treatment further significantly decreased MMP and mitochondrial activity, which was slightly up regulated by PGC-1α over expression ( Fig 6D&E) .
These observations show that PGC-1 over expression partially prevents TORC1 knockdown mediated increased susceptibility to 3-NP and reductions in MMP in the STHdhQ111 striatal cells.
TORC1 knock down enhances neurodegeneration in the striatum of NLS-N171-82Q HD transgenic mice
We next examined whether a knockdown of TORC1 in the striatum of NLS-N171-82Q HD transgenic mice makes them more susceptible to mitochondrial dysfunction and neurodegeneration. We stereotaxically injected TORC1 siRNA or scrambled sequences directly into the striatum of NLS-N171-82Q HD mice. We observed about 70% decreases in TORC1 mRNA expression in the striatum following TORC1 siRNA but no effect of scrambled sequence (data not shown). We investigated the effects of TORC1 knockdown on neuron viability by observing Fluoro Jade-B staining in the striatum (Fig 7A and 7B) . Fluoro Jade-B is a fluorescein derivative which specifically binds to neurons undergoing neurodegeneration. Intra-striatal injection of scrambled sequence siRNA did not produce Fluoro Jade-B positive neurons. We observed a significantly increased number of Fluoro Jade-B stained degenerating neurons in the striatum of NLS-N171-82Q HD mice following 3-NP injection (Fig 7A and 7B ). TORC1 knockdown also resulted in increased numbers of degenerating neurons in the striatum (Fig 7A   and 7B ). TORC1 knock down made the NLS-N171-82Q HD mice more susceptible to 3-NP toxicity, as shown by the presence of a significantly increased number of degenerating neurons in the TORC1 siRNA with 3-NP group (Fig 7A and 7B ). We next investigated nuclear chromatin condensation by Hoechst staining in the striatum of the NLS-N171-82Q mice after TORC1 knockdown. There was significantly increased chromatic condensation, and nuclear fragmentation in the NLS-N171-82Q mice striatum following TORC1 siRNA treatment, as compared to scrambled sequence ( Fig 7C) . These results show that a knock down of TORC1 produces cell death and striatal neurodegeneration in HD mice.
Huntingtin knock down prevents transcriptional repression of TORC-1, CREB and PGC-1α in huntingtin striatal cells
In order to see whether mutant huntingtin affects TORC1, CREB and PGC-1α transcriptional activity, we knocked down mutant huntingtin expression in huntingtin striatal cells using a specific target shRNA sequence against mutant huntingtin (Fig 8) . At base line TORC-1, CREB and PGC-1α mRNA expression were significantly decreased by 48%, 47% and 42% respectively in scrambled shRNA transfected HD STHdhQ111 cells as compared to control STHdhQ7 cells ( Fig 8) . We found that knockdown of mutant huntingtin with shRNA resulted in a significant increase of TORC-1, CREB and PGC-1α mRNA expression in STHdhQ111 cells as compared to control STHdhQ7 cells (Fig 8) .
Discussion
There is substantial evidence that mitochondrial dysfunction, transcriptional dysregulation and bioenergetic defects play an important role in the pathogenesis of HD (1, 11). Mutant Htt causes aberrant transcriptional regulation by binding to several transcriptional regulators, and interfering with their function (13) (14) (15) (16) . In particular, an interaction of mutant Htt with expression of both CREB and PGC-1α has been implicated in HD pathogenesis (13, 17, 21, 25) . Furthermore, mutant Htt interferes with formation of the CREB/TAF4 complex that regulates transcription and expression of the gene encoding PGC-1α (21) . Impaired transcription and function of PGC-1α contributes to the mitochondrial dysfunction and plays an important role in HD pathogenesis (19) (20) (21) 24 ). An involvement of PGC-1α in HD pathogenesis was initially suggested by the observation that PGC-1α knockout mice show spongiform lesions in the striatum, the brain region most affected in HD (34, 35) . The initial reports showed reduced PGC-1α expression in both striatal cell lines expressing mutant huntingtin, as well as in the striatum of HD transgenic mice, and in striatal tissue from postmortem HD patient brains (21, 24) . We observed a significant reduction in PGC-1α mRNA expression and activity in the striata and muscle of HD transgenic mice, muscle biopsies from HD patients and cultured myoblasts from HD patients (19) (20) (21) 24) . Furthermore, expression of 24 out of 26 genes co-activated by PGC-1α was significantly reduced in postmortem brain tissue of HD patients (24) . The expression of PGC-1α's downstream target genes such as Tfam, NRF-1, NRF-2, and CytC as well as mitochondrial biogenesis are also impaired in HD (19, 20) . There is marked hypothermia at baseline and following cold exposure in several HD mouse models (24) .
Following cold exposure, the expression of UCP-1, a PGC-1α target gene involved in adaptive by guest on November 8, 2016 http://hmg.oxfordjournals.org/ Downloaded from thermogenesis, does not increase in brown adipose tissue from HD mice relative to wild-type animals, resulting in hypothermia (24) . There is also impairment of PGC-1α activation and mitochondrial biogenesis in response to energy deprivation conditions in HD mice and myoblasts from HD patients (19, 20) .
The expression of CREB and CRE dependent transcription is also reduced in HD transgenic mice and HD cell models (11, 13, 14, (17) (18) (19) (20) 46) . CREB knockout mice show apoptosis of striatal neurons, and a phenotype similar to HD (33) . CREB deficient mice are more sensitive to 3-NP, and when crossed to YAC128 HD transgenic mice, the motor impairment is significantly accelerated (47). A partial loss of CREB-binding protein reduces the life expectancy of N171-82Q mice (48) .
TORCs are co-activators of CREB which enhance CREB dependent gene transcription, PGC-1α promoter activity, PGC-1α gene transcription and mitochondrial biogenesis (27, 28) . A screen for transcriptional activators of PGC-1α expression was carried out with 10,000 full length human cDNAs, examining induction of the PGC-1α promoter (28) . TORC1 was the most potent activator of PGC-1α expression, but TORC2 and TORC3 were also highly active (28) . Forced expression of TORCs in primary muscle cells induced the endogenous mRNA of PGC-1α and its downstream genes and increased numbers of mitochondria. TORC1 enhances dendritic growth of developing cortical neurons and enhances neuronal survival after ischemia through positive regulation of CREB-target gene transcription (29, 32). TORC1 is required for long-term potentiation in hippocampal neurons (40, 49) . TORCs also promote stress resistance, and maintain energy balance by induction of CREB target genes in the brains of Drosophila under starvation conditions (30, 31) . There is strong evidence showing that mutant Htt interferes with CREB and PGC-1α transcription in HD, and that this may play an important role in HD We found significantly decreased TORC1 mRNA expression in the striatum of NLS-N171-82Q, R6/2 and Hdh-Q111 HD transgenic mice as compared to their respective wild type animals. TORC2 mRNA expression was significantly decreased in NLS-N171-82Q mice, while TORC3 was unchanged in all three HD transgenic mice lines. We also found a significant decrease of TORC1 protein levels in the striatum of all three HD transgenic mouse lines. We observed significantly decreased expression of TORC1 mRNA in HD STHdhQ111 striatal cells.
These results show that down regulation of TORC1 mRNA and protein levels occurs in both HD transgenic mice and striatal cells, while TORC2 and TORC3 were unchanged or in one instance decreased. TORC1 mRNA and protein levels were also significantly decreased in the striatum of HD patients as compared to age matched control subjects. We found a significant increase in TORC3 in the striatum of HD patients, which may be compensatory, but is of uncertain significance since TORC3 levels are relatively low in the nervous system.
We investigated the effects of TORC1 over expression on CREB and PGC-1α expression in HD STHdhQ111 striatal cells. TORC1 over-expression produced a significant increase in TORC1 mRNA and protein levels in the huntingtin striatal cells. TORC1 over expression also resulted in a significant up regulation of CREB transcript expression and protein levels. Several studies have shown that there is reduced CREB and CBP expression in Htt transfected cell lines and transgenic mice, which can be reversed by increasing cAMP which activates CREB (50, 51) .
The phosphodiesterase type IV inhibitor rolipram increases CREB phosphorylation, and improves behavior and neuropathologic abnormalities in the R6/2 transgenic mouse model of HD (51) .
Rolipram inhibition of phosphodiesterase IV also prevents sequestration of CREB-binding protein by guest on November 8, 2016 http://hmg.oxfordjournals.org/ Downloaded from and protects striatal parvalbumin interneurons in the R6/2 mouse model of HD (50) . Inhibition of the striatal specific phosphodiesterase PDE10A increases phosphorylated CREB and BDNF and ameliorates striatal and cortical pathology, and motor impairments in the R6/2 mice (52) .
Depletion of CREB binding protein has been linked to cell death mediated by mutant Htt in vitro (14, 53, 54) .
Consistent with CREB up regulation, over expression of TORC1 also caused a significant up regulation of PGC-1α mRNA expression and its promoter activity. These observations are consistent with a previous study suggesting that TORCs mediated increases of PGC-1α transcription and function are CREB dependent, and were inhibited in the absence of CREB (28) .
CREB plays an important role in the regulation of PGC-1α and its ability to induce gluconeogenesis, and to increase in response to H 2 O 2 (55, 56) . The regulation of PGC-1α by CREB/TAF4-dependent transcription was shown to be impaired in HD (21) . TORC2 promotes fasting induced hepatic gluconeogenesis by inducing the expression of PGC-1α (57, 58) .
Drosophila deficient in TORC, show impaired metabolism and they are strongly sensitive to starvation and oxidative stress (30) . Our results show that TORC1 over expression enhances both CREB and PGC-1α mRNA and protein levels in HD.
Recent studies showed a decrease in expression of PGC-1α target genes and mitochondrial biogenesis in HD transgenic mice, and HD patients (19, 20, 25) . PGC-1 in concert with CREB regulates mitochondrial biogenesis and cellular respiration, by modulating the expression of transcription factors such as NRF-1, Tfam, and CytC (42) (43) (44) . Therefore, increased CREB mRNA expression and PGC-1 promoter activity observed following TORC1 over expression prompted us to study, whether increased TORC1 expression also affects PGC-1 downstream target genes, and mitochondrial DNA content in the huntingtin striatal cells. We found significantly increased with the TORC1-CREB interaction to repress BDNF. Therefore, there are a number of potential therapeutic avenues which can be manipulated to increase TORC1 expression, and exert beneficial therapeutic effects in HD. One potential means would be to increase NAD, which activates Sirt1. A pharmacologic activator of TORC1 is tanshinone IIA, which protects against focal ischemic brain injury by inducing nuclear translocation of TORC1, and upregulation of expression of TORC1, pCREB and BDNF (62) . Our findings therefore suggest that agents which increase TORC1 expression and activity may be an attractive approach for the treatment of HD.
Material and Methods:
Transgenic animals
The NLS-N171-82Q mice with a C3H/C57Bl6 background were kind gift from Dr. David Borchelt. R6/2 and HdhQ111 mice were obtained from Jackson Laboratory (Bar Harbor, ME). Experiments were carried out using procedures that minimized pain and discomfort. All experiments were conducted within National Institutes of Health guidelines for animal research and were approved by the Institutional Animal Care and Use Committee.
NLS-N171
Gene Expression Analysis by qRT-PCR
Total RNA was isolated from striatum of WT and HD mice and HD patients and striatal cells using the TriZol Reagent. Genomic DNA was removed using RNase free DNase (Ambion, USA).
RNA pellets were resuspended in DEPC-treated water (Ambion). Equal amounts of RNA were revere transcribed using the Superscript first strand synthesis system with Oligo-dT (Invitrogen, (1:1,000, Cell Signaling, USA), CREB (1:1,000, Cell Signaling, USA), pCREB (1:500, Cell Signaling, USA) and -actin (1:10,000, Chemicon, USA). Membranes were then washed three times with TBST and incubated for 1h with HRP-conjugated secondary antibody and the immunoreactive proteins detected using a chemiluminescent substrate (Pierce, USA) according to the manufacturer's instructions. Films were scanned by film processor (Konica Minolta & Graphic Inc, SRX-101A, USA). Protein expression was quantified using Scion Image for Windows (NIH, USA).
Mitochondrial DNA (mtDNA) Content
Total DNA was isolated by a standard phenol-chloroform extraction procedure. Fragments of the mitochondrial COX-II gene and the nuclear 18S gene were amplified in duplicate by quantitative real-time PCR (45) . The absolute content of mtDNA was expressed as the mtDNA-to-nuclear-DNA ratio (COX-II mtDNA/18S nuclear DNA).
Striatal cell culture
Wild type STHdhQ7/Q7 (expressing endogenous normal huntingtin) and STHdhQ111/Q111 striatal cells (expressing endogenous mutant Htt; 111CAG repeats) were cultured. Both types of cells were cultured in Dulbecco's modified Eagle medium containing 1mM L-glutamine, 25mM D-glucose, 1% G418, 400mg/ml geneticin and 10% fetal bovine serum at 33 0 C with 5% CO2.
PGC-1α Luciferase Reporter Assays
STHdhQ7 and STHdhQ111 cells were transiently transfected with the 2Kb PGC-1α promoter luciferase reporter having sequences of mouse PGC-1α promoter (pGL3-PGC1α-Luc) between +78 to -2533 (Addgene, USA) using Lipofectamine reagent (Invitrogen). Cells were also cotransfected with pGL3-PGC1α-Luc and TORC1 plasmid (kind gift from H. Takemori, Japan).
Luciferase activity was determined using a dual luciferase assay as per manufacturer instructions (Promega, USA). 
TORC1 over expression and knock down
PGC-1α and TORC-1 co-transfection
STHdhQ7 and STHdhQ111 cells were co-transfected with 1µg pcDNA-PGC1α plasmid (Addgene, USA) and TORC1 shRNA and scramble plasmid constructs.
3-NP treatment
After 36 hrs of TORC1 over expression and knock down, cells were treated with 100µM 3-NP for two hours, followed by MMP and mitochondrial activity analysis. 
Fluoro-jade B and Hoechst labeling
Fluoro-jade B and Hoechst labeling was performed to monitor degenerating neurons and chromatin condensation respectively in the striatum region of NLS-N171-82Q HD transgenic mice after TORC1 knock down. In brief 20µm -thick coronal sections across striatum were cut using a cryostat, mounted on slides, stained with Hoechst nuclear stain (Invitrogen, USA) and
Fluoro-jade B (Millipore, USA) as per manufacturer instruction.
Statistical analysis
Statistical analysis was performed using GraphPad InStat statistical analysis software version 3.05
for Windows (San Diego, CA, USA). The mean significant difference in the experimental groups was determined using one-way analysis of variance (ANOVA) followed by Tukey-Kramer posthoc multiple comparisons test. Values of p<0.05 were considered to be statistically significant.
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HD transgenic mice
A-B) TORC1 knockdown was done by stereotaxic injection of TORC1 siRNA and scrambled sequences directly into the striatum of NLS-N171-82Q HD mice. Fluoro Jade-B stained degenerating neurons in the striatum of NLS-N171-82Q HD mice are significantly increased by 3-NP injection and TORC1 knock down (Fig 7A and 7B) . TORC1 knock down made NLS-N171-82Q HD mice more susceptible to 3-NP toxicity, shown by a significantly increased number of degenerating neurons in the TORC1+3NP injected group (Fig 7A and 7B ). *p<0.05, n=5 mice, *versus NLS-N171-82Q, # versus NLS-N171-82Q+3NP, $ versus NLS-N171-82Q+TORC1 siRNA. Scale bar=200µm C) Nuclear chromatin condensation and nuclear fragmentation analysis by Hoechst staining in the striatum of NLS mice after TORC1 knockdown. Increased chromatin condensation, and nuclear fragmentation in the NLS mice striatum, is observed following TORC1 knockdown, as compared to scrambled sequence. Scale bar=50µm 
